Feed CYLYF
Summary
29 / 100 · Bulios Score
Valuation 100Growth 0Profitability -Quality 0Debt 0Stability 45
What speaks for it
- The price moves less than the market (beta 0.23).
What to watch
- It passes only 1 of the 9 points of the Piotroski financial health test.
- For every 100 CAD of shareholders' equity it carries 2,445 CAD of debt.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapIs it growing?
It is shrinkingRevenue (CAD)
20202021202220232024
Diluted EPS (CAD)
20202021202220232024
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Cash and short-term investments $150.3K
Debt $2.44M
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.